AddThis Feed Button "Frequently Copied, Never Duplicated"

Showing posts with label pain. Show all posts
Showing posts with label pain. Show all posts

Tuesday, November 01, 2011

Got PAIN? Let Us Help You with Natural and Custom Remedies

This isn't new news.  I've read and re-read articles on this very topic for years and I have yet to see mainstream medicine, CDC, or even Big PhRMA do anything to address this other than a move to control it by and or through legislation (which really has yet to be effective).

I have yet to see a real patient-centered approach used to focus on a person's real needs for pain treatment and a very directed and proactive appraoch to this issue.

See our Natural Pain Relief information linked below or ask us about Health Forensics or customized pain relief remedies.

Painkiller overdose 'epidemic' strikes US
Kerry Sheridan AFP
November 2, 2011

Lethal overdoses from prescription painkillers have tripled in the past decade and now account for more deaths than heroin and cocaine combined, US health authorities say. The quantity of painkillers on the market is so high that it would be enough to medicate every American with a standard dose of Vicodin every four hours for one full month, according to the Centers for Disease Control and Prevention (CDC). "The unfortunate and in fact shocking news is that we are in the midst of an epidemic of prescription drug overdose in this country. It is an epidemic but it can be stopped," said CDC chief Thomas Frieden. "In fact, now the burden of dangerous drugs is being created more by a few irresponsible doctors than by drug pushers on street corners." The CDC Vital Signs report focused on opioid pain relievers, including oxycodone, methadone and hydrocodone, better known as Vicodin, which have quadrupled in sales to pharmacies, hospitals and doctors' offices since 1999. Last year, 12 million Americans reported taking prescription painkillers for recreational uses, not because of a medical condition. The number of deaths from overdoses of opioid pain relievers has more than tripled from 4000 people in 1999 to 14,800 people in 2008.

The epidemic is at its height among middle-aged white men and American Indians or Alaska natives, the CDC said.
Pain Relief Naturally

Rural and poor areas tend to have the highest prescription drug overdose death rates.

Deaths from prescription drugs made up almost 75 per cent of overdose deaths in which a drug was specified on the death certificate, the CDC said, noting that deaths and hospitalisations have increased in parallel with the boost in supply. The sales rate of the three opioids included in the study reached 7.1 kilograms per 10,000 population last year, or the same as 710 milligrams per person in the United States. "Enough OPR (opioid pain relievers) were prescribed last year to medicate every American adult with a standard pain treatment dose of five milligrams of hydrocodone (Vicodin and others) taken every four hours for a month," the CDC said. Even though a relatively small portion of the US population admits abusing prescription painkillers, the costs to health insurance companies are huge, $US72.5 billion per year, according to the report. States could do a better job of regulating the problem via drug monitoring records and insurance claims information that "can identify and address inappropriate prescribing and use by patients", the report said. More laws targeting so-called "pill mills", which are prescribing at higher than normal rates in particularly affected states, could also cut back on the problem, it said. "State policy can make a huge difference in either controlling or allowing this epidemic to proceed," said Frieden. "States should rigorously monitor who is prescribing and to whom."

Selections from Natural Health News
Jul 28, 2011
Hands on Healing for Pain and So Much More. Reading news early this morning I came upon a couple of article that were of interest because they involved energy healing. If you'd like a copy of our Reiki brochure please ...
Sep 30, 2011
Dr. Oz Raises Awareness of Pain in America! The Dr. Oz Show interviewed top doctors this week about a familiar subject— pain. Dr. Oz was shocked to learn what so many of us live with every day. Pain is prevalent, finding ...
Sep 29, 2008
There are many natural options for people experiencing pain that are as, if not more, effective that pharmaceuticals that may also promote addiction. The key to this, however, remains making the relief of pain tailored ...
Apr 28, 2010
To me it is interesting that news of the well known - for a very long time - benefits of cayenne as a pain remedy reports as if no one has ever heard of this benefit. But in case you've been in the dark on this wonderful ...

Friday, September 30, 2011

Raising Awareness Good, What's Ignored, Not...


As so many cling to every word from Dr. Oz, this is a very telling comment in regard to the lack of fully factual information you get on his show -


"The Dr. Oz Show" has gained the trust of millions of consumers. Recommendations of ingredients on his TV program move markets in a way that no other media mention can. Despite issues raised with the accuracy of some of the information relayed on the show." Source

Another organization says - 
Dr. Oz Raises Awareness of Pain in America! The Dr. Oz Show interviewed top doctors this week about a familiar subject— pain. Dr. Oz was shocked to learn what so many of us live with every day. Pain is prevalent, finding good pain care is hard, and women face discrimination when it comes to pain assessment and treatment.
How ever you interpret this we think he can do a much better job in educating you about the benefits of natural healing.


If you want to know more 

Selections from Natural Health News




Mar 28, 2010
I happened to notice a link to the Oprah show bulletin broad and their Q & A for Dr Oz having to do with vitamin D, Fosamax, cell phones and irregular heart beat. What stuck me is that one of the queries posted was by a ...

Mar 17, 2010
Oprah and Oz: Maybe their answers are missing some... New from Tanka Bar · When a little hype can cause big health problems · Data Safety · Vitamin A and Arsenic Effectively Treat Leukemia, . ...
Aug 08, 2011
Earlier than this, along with an expert on the subject, we tackled mis-information being promoted by Dr Oz's "Real Age". ... Natural Health News: Sunscreen Allergies. May 15, 2011. In 2008 Natural Health News reported on ...
Mar 12, 2009
You will need: 1 quart of organic raw apple cider vinegar 1 pound garlic cloves 8 oz. comfrey root 4 oz. each of oak bark, marshmallow root, mullein flowers, rosemary flowers, lavender flowers, wormwood, black walnut leaves ...

Thursday, July 28, 2011

Hands on Healing for Pain and So Much More

Reading news early this morning I came upon a couple of article that were of interest because they involved energy healing.

If you'd like a copy of our Reiki brochure please make a donation through our PayPal link in the right column. Please put REIKI in the note section of your donation to us on PayPal.


One was from the Milwaukee Journal Sentinal. The article described a difficult situation for a woman, and it did discuss some troubling behavior by this practitioner. However, in general my feeling was that it was generally negative toward healing. The writer actually interviewed no one that could shine some positive light on this type of work.


Here is the article and other information.


Here are my comments to the writer -
The second article that caught a bit of my ire came from Everyday Health.
I just wanted to comment that while you article is good it hardly seems fair as it paints a negative picture of all intuitive healers.


I have the sense to know what is wrong with people by looking at them. I do not however do any type of work similar to what the man did in your article. He was certainly out of bounds and for this he should be prosecuted.


Spinal manipulation is not always chiropractic. Medical providers that specialize in osteopathy can do this and the new hybrid type of naturopaths do this as well. Even some physical therapists licensed massage therapists do this too as you mention.


There are specialized chiropractors that do use a very fast and forceful type of adjusting. I have experienced it and I do not like it. I am however an advocate of chiropractic for many situations.


I hate to counter Dr. Sampson but he is totally incorrect about the lack of scientific studies into healing. However this is the medical closed-mind set and it is also the same of the US government (bias) even though there is an office of alternative health. His attitude is clear when he refers to all of this as *quackery*.
I am a bit surprised that you did not make an effort to talk with Barbara Brennan. You would find a great amount of science behind healing if you had contacted her. There are many other sources, including MDs that write on this subject and do study it. I began studying this area in 1972 and many of my teachers were medical professionals.


I will tell you though that bureaucratic attacks on people by state departments can be extremely egregious and corrupt. I am not surprised at the record in your state.


Patient records ARE the property of the "patient": Destroying them or being advised by an attorney not to give them to a person about whom the record is written is violation of patient rights and regulations covering health related records. Maybe this woman should file a bar complaint against Wu's attorney and seek recovery from him for obstructing justice.

I'm a longtime Reiki Master, teacher, and practitioner.  In general I thought this article too was slanted to the negative.  The other concern I had too when reading it was the fact that it stressed "that standardization is lacking" in the United States.  

Since Reiki is a practice that facilitates energy, it is not "similar to massage", and it is very much based on following the lead of the person receiving the treatment.  In this sense standardization would defeat the purpose of this ancient healing technique.

The article made some good points, but it labelled Reiki as "alternative medicine" which it is not.  

What are your thoughts?

Selections from Natural Health News

Natural Health News: Reiki, Healing, Japan, the World
Mar 14, 2011
It was due to this earthquake, named Kanto Daishinsai, that Reiki and Usui Sensei became well- known in Japan. The only reason for us practicing Reiki today was the loss of hundreds of thousands of lives in the past. ...


Natural Health News: Energy Healing Moves Mountains
Aug 26, 2010
I believe in this work to such a degree that I offer Reiki Level One to people by donation rather than charging a high fee as I often see advertised on the web or in a close by city. The thing is that it does work, ...


Natural Health News: herbalYODA Joins Expert Panel
Mar 19, 2009
In addition Gayle is a Reiki master and teacher, deeply involved in the study and use of American indigenous herbalism, and a certified Voice BioAnalysis practitioner. She holds many other professional certifications. ...


Don't let flu hit you full force...
Jan 31, 2008
Mushrooms (reiki, mitake, shiitake) Colostrum – 4 capsules. Vitamin C – 2-4 grams. Vitamin A – 10000-25000 IU with 400 IU vitamin D Zinc – 25 mg with copper 2 mg. Influenzinum is a specific homeopathic preventive for the flu. ...

Wednesday, August 18, 2010

Putting Pain Sufferers Health at Risk

In its infinite wisdom, FDA is planning to consider Cymbalta for pain relief -
-FDA Panel to Consider Pain Indication for Antidepressant (excerpt)
Patients in the duloxetine arms were more likely to discontinue treatment because of adverse events, including nausea, sleep disturbances, dizziness, dry mouth, somnolence, constipation, and fatigue. Most of the events were dose-dependant.
Duloxetine use also appears to be associated with an increased risk of Stevens-Johnson syndrome, a skin disease that usually results from a drug reaction, as well as another form of the disease called toxic epidermal necrolysis. The FDA reviewers recommended that, if duloxetine is given the chronic pain indications, it should carry warning labels about the increased skin disease risks.
The FDA also has concerns about duloxetine's risk of serious liver toxicity, already included in the drug's labeling.
No deaths were reported during the trials.
The safety findings aren't new or unexpected and are very similar to duloxetine's current safety label, the FDA reviewers said.
The drug also carries a boxed warning for suicidality in children, adolescents, and young adults taking antidepressants for major depressive disorder and other psychiatric disorders.
"...duloxetine is not universally tolerated nor free of safety risks," wrote Eli Lilly staff in the company's briefing documents posted on the FDA's website. However, the safety profile is "well-characterized" and not any different for chronic pain patients than it is for other patients who are already using the drug.

Consider that you do encounter much higher risk with these and may other drugs used for pain relief. Lyrica for example depletes your platelets and they don't mention that in the TV ads.
You might want to learn more about natural pain relief.


from Natural Health News Search
Sep 07, 2008
The FDA also said it is evaluating reports of urinary retention with Eli Lilly's antidepressant Cymbalta, and skin melanoma with Biogen and Elan Corp's multiple sclerosis drug Tysabri. Biogen spokeswoman Shannon Altimari said two cases ...
Feb 13, 2009
When cymbalta first came out, it was the "wonder drug" that was going to end my troubles. Well, it almost ended ME altogether!!! I had horrible suicidal ideations, and I even brought home insulin and a syringe to do myself in (I'm a ...
Dec 28, 2007
In October, the FDA told Lilly to stop falsely claiming antidepressant Cymbalta produced “significantly less pain interference with overall functioning” and start mentioning its side effect of liver toxicity. ...
Nov 18, 2008
Duloxetine (Cymbalta) * Fluvoxamine (Luvox) * Mirtazapine (Remeron) * Trazodone (Desyrel) * Nefazodone (Serzone) * Venlafaxine (Effexor) The guideline also calls for physicians to modify treatment if patients fail to respond adequately 
Jun 02, 2010
Not all SSRI antidepressants were found to increase cataract risk, although this may be because not enough people in the study were taking them for the researchers to detect a risk. Risk was found for three different antidepressants:
Jul 06, 2007
In June 2001 I posted a response to the just reported Andrea Yates case, directing my comments to the negligence of the prescribing physician for the overload of SSRI and related psychiatric drugs, including Haldol. ...
Nov 26, 2008
Prozac use has shown that women who took the SSRI (and fluoride based) antidepressant during the first three months of pregnancy gave birth to four times as many babies with heart problems as women who did not. ...
Mar 16, 2009
SSRI anti-depressants are based in fluoride and are endocrine disruptors. All campus shootings have been associated with people who have been taking SSRI anti-depressants, which recently have been proven - AGAIN - to be ineffective for ...

Monday, June 07, 2010

A New Look at Fibromyalgia?

If there were to be something coming from this story I'd like to see proper thyroid testing, nutritional counseling, and supplement support.

I say this because I worked for several years as a resource person for a large urban hospital FMS/CFIDS group.

I also worked with an MD and an LMP to develop and monitor a natural approach to fibromyalgia.

Guess What? Many of our group lost the FMS and the diagnosis!

New criteria proposed for diagnosing fibromyalgia

ScienceDaily (2010-06-06) -- The American College of Rheumatology is proposing a new set of diagnostic criteria for fibromyalgia that replaces the tender point test with a rating system that includes common symptoms such as fatigue, sleep disturbances, and cognitive problems, as well as pain. ... > read full article

Wednesday, April 28, 2010

Chili Counters Pain

Natural Health News has about nine articles that include cayenne. You'll find more here on our original domain, on line since 1991.

Learn more

To me it is interesting that news of the well known - for a very long time - benefits of cayenne as a pain remedy reports as if no one has ever heard of this benefit.

But in case you've been in the dark on this wonderful substance for pain, here's the newest -
Studying chilli peppers is helping scientists create a new type of painkiller which could stop pain at its source.
And if you'd like to get some of our great cayenne ointment, just send us an email for more information and ordering.

Friday, October 17, 2008

Pfizer hedging its bets? UPDATE

Today Pfizer agrees to pay out $894 million to settle lawsuits over Celebrex and Bextra. Other NSAIDS still show a link to heart disease but this is one of the most readily preventable health conditions we know of and other posts on this blog give you some of that data. For pain and inflammation there are many excellent natural remedies as well as one of the natural products I use from time to time that has been tested at Dana Farber.
$894 million deal ends pain of Pfizer's lawsuitsBy Linda A. Johnson, Ap Business Writer
17 October, 2008
TRENTON, N.J. – Drug giant Pfizer Inc. has reached an $894 million deal to end most of the lawsuits over its two prescription pain relievers, the popular Celebrex and a similar drug, Bextra, no longer on the market.

The world's biggest drugmaker said Friday it has agreements in principle to end more than 90 percent of personal injury lawsuits brought by people claiming the pills caused heart attacks, strokes or other harm.

The settlement includes roughly 7,000 personal injury cases, mainly plaintiffs who took since-withdrawn Bextra, said plaintiff attorney Perry Weitz. He represents nearly 2,000 claimants, about 10 percent of them relatives of people who died.

"It gives Pfizer closure and the claimants their money sooner, rather than later or never at all," Weitz said.

Pfizer hopes to finalize claims covered by the settlement, which now includes up to 92 percent of plaintiffs, by year's end. It also hopes to include many of the remaining claimants in the settlement and will fight any remaining personal injury suits with court motions or at trial, General Counsel Amy Schulman told The Associated Press.

"I don't think either side has an interest in protracting this," Schulman said in an interview.

Weitz said plaintiff lawyers will "have issues" with Pfizer "if their claimants aren't paid before the end of the year."

In early trading, Pfizer shares were down 47 cents, or 2.8 percent, at $16.50.

Schulman said the deal comes after two important court rulings — one by a New York state judge overseeing many of the state-level personal injury cases and the other by a federal judge in San Francisco coordinating pretrial steps in federal lawsuits over the drugs.

"We teed up some pretrial motions for a court ruling on whether there was significantly reliable evidence that would allow an expert to testify as to whether there was an increased risk of heart attack and stroke at the most common dose," 200 milligrams, Schulman said. Both judges ruled that was not the case, she said.

The proposed deal also would end suits by insurers and patients seeking to recover what they spent on Bextra and Celebrex, as well as claims by 33 states and the District of Columbia that Pfizer improperly promoted Bextra.

Out of the total settlement, $745 million will go to settle personal injury cases, $60 million will cover settlements with attorneys general in the 33 states and the District of Columbia, and $89 million will cover consumer fraud class action cases over reimbursement for money spent on the two drugs. Two additional states, Louisiana and Mississippi, still have pending cases regarding Pfizer's promotion of the drugs.

New York-based Pfizer withdrew Bextra from the market in 2005, a year after Merck & Co. withdrew its Vioxx, a similar drug.

The Vioxx withdrawal, which triggered an avalanche of lawsuits against Merck, also raised concerns about the safety of other medicines in the same class, called Cox-2 inhibitors. They were heavily touted by their makers as superior to traditional nonsteroidal anti-inflammatory drugs, or NSAIDs, such as ibuprofen, because they block an enzyme involved in promoting inflammation but — unlike NSAIDs — don't block an enzyme that protects the stomach from bleeding and other side effects.

Other NSAIDs, such as ibuprofen and naproxen, have also been linked to increased heart risks.

Celebrex is the only Cox-2 inhibitor that the Food and Drug Administration has allowed to remain on the U.S. market.

Attorney Christopher Seeger, a member of the plaintiffs steering committee, said he'll "have no problem recommending" the settlement to the roughly 400 clients he represents.

"We're very satisfied with the deal," Seeger said.

Schulman said the company's negotiations with opposing lawyers had been under way for some time but picked up in the late summer.

"Litigation can be distracting, and putting these matters behind us helps our shareholders and, most importantly, patients and doctors," Schulman said.

Weitz noted that it took four or five years to get through trials for less than 20 cases in the massive Vioxx litigation, because the court system can only handle a limited number of cases at a time.

Pfizer will take a pretax charge of $894 million to its third-quarter earnings, which it is scheduled to report on Tuesday.

Merck, based in Whitehouse Station, N.J., has begun paying a $4.85 billion settlement to end about 50,000 lawsuits brought by people claiming Vioxx cause heart attacks, ischemic strokes or death. It still faces other litigation over the former blockbuster arthritis treatment.

Copyright © 2008 The Associated Press.

Pfizer to Drop Development of Certain Drugs
by Shelley Wood, Heartwire 2008. © 2008 Medscape

October 3, 2008 (New York, NY) — Pfizer is getting out of the cholesterol-lowering game to focus on what it perceives to be more lucrative diseases, according to an internal memo obtained by Forbes [1]. And for the most part, the chosen "disease areas" don't include the heart.

In the memo, Martin Mackay, president of Pfizer Global Research & Development (R&D), informed his staff that the company plans to "exit" the fields of atherosclerosis/hyperlipidemia, heart failure, obesity, and peripheral arterial disease.

Instead, the company, whose cholesterol-lowering drug atorvastatin (Lipitor) is the world's top-selling drug, says it is turning its attention and R&D dollars to cancer, diabetes, Alzheimer's, pain remedies, and mental health as its "higher-priority areas."

The news comes in the wake of the flop of Pfizer's hoped-for new flagship, torcetrapib, a CETP inhibitor that was widely predicted to be the company's next blockbuster drug. While CV drugs have been the major moneymakers for Pfizer in recent years, those days are drawing to a close. In addition to Lipitor, which will lose patent protection in 2011, Pfizer's other major player in the CV drug arena is Norvasc (amlodipine), which came off patent in 2007.

Among the lower-priority "disease areas" where the company says it will continue working are thrombosis and transplant, the memo notes.

Contacted by heartwire, a handful of leaders for some of the major Pfizer-sponsored trials in cardiovascular disease over the past decade declined to comment on the company's announcement or speculate on what it might mean to the field of CV drug development--with one exception. Dr John Kastelein (Academic Medical Center, Amsterdam, the Netherlands), who was an investigator in the Pfizer-sponsored ASAP, TNT, and IDEAL trials, called Pfizer "a real powerhouse" in the CV drug arena.

"I kind of knew this was coming, but when you see it in print, it still hits hard," he told heartwire. "I think this is very, very significant both for the company itself and for the whole field of CV drug development. Pfizer had truly excellent people in the development arm of their company for CV and metabolic drugs, and they've contributed to this whole notion that you need more robust LDL lowering and that that's better than mild LDL lowering, which has become one of the axioms of CV prevention. And if they're stepping out now, that not only signifies their own problems, but it also signifies the problems in CV drug development, and how incredibly difficult and costly it has become to bring new drugs forward. And that's not good for patients."

Kastelein predicts that drug companies, having "lost faith" somewhat in HDL-raising therapies, will need to look more closely at anti-inflammatory drugs in the setting of coronary artery disease. "But there, the problem is, if you have no biomarkers whatsoever to do even dose-finding studies, you need to move from relatively small phase 2 trials to incredibly large, hard-outcome studies, which is taking quite a risk," he said. And that, at least for Pfizer, is too much risk.

"Everyone, not just Pfizer, is realizing that the days of the really big blockbuster drugs are over. And what is going to replace that are drugs in a class that are 10 times or 100 times more difficult to develop, so the risks are much higher. And these days, after Avandia and ezetimibe, everything is about safety. This means the FDA is forced, by public and colleague pressure, to demand even larger databases before drugs are going to market, which is of course making it more expensive. It's a cycle that's very hard to break."

Calls to Pfizer were not returned before this story was published.

Herper M. The Pfizer memo. Forbes, September 30, 2008. Available at: http://www.forbes.com/business/2008/09/30/pfizer-drug-agenda-biz-bizhealth-cx_mh_0930pfizermemo.html.

The complete contents of Heartwire, a professional news service of WebMD, can be found at www.theheart.org, a Web site for cardiovascular healthcare professionals.